DNA hypomethylation mediates immune response in pan-cancer

DNA hypomethylation mediates immune response in pan-cancer

Abnormal DNA methylation is a fundamental characterization of epigenetics in cancer. Here we demonstrate that aberrant DNA methylating can modulate the tumour immune microenvironment in 16 cancer types. Differential DNA methylation in promoter region can regulate the transcriptomic pattern of immune...

Full description

Bibliographic Details
Main Authors:	Chunlong Zhang, Qi Sheng, Ning Zhao, Shan Huang, Yuming Zhao
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2023-12-01
Series:	Epigenetics
Subjects:	dna methylation pan-cancer immune hypomethylation biomarker
Online Access:	http://dx.doi.org/10.1080/15592294.2023.2192894

Similar Items

Promoter hypomethylation and overexpression of TSTD1 mediate poor treatment response in breast cancer
by: Muhamad Ansar, et al.
Published: (2022-11-01)

Cross-tissue patterns of DNA hypomethylation reveal genetically distinct histories of cell development
by: Timothy J. Scott, et al.
Published: (2023-10-01)

Immunomodulatory Properties of DNA Hypomethylating Agents: Selecting the Optimal Epigenetic Partner for Cancer Immunotherapy
by: Carolina Fazio, et al.
Published: (2018-12-01)

Comparative Analyses of Sperm DNA Methylomes Among Three Commercial Pig Breeds Reveal Vital Hypomethylated Regions Associated With Spermatogenesis and Embryonic Development
by: Siqian Chen, et al.
Published: (2021-10-01)

Pan-Cancer Methylated Dysregulation of Long Non-coding RNAs Reveals Epigenetic Biomarkers
by: Ning Zhao, et al.
Published: (2022-05-01)

A Hypomethylated population of <it>Brassica rapa</it> for forward and reverse Epi-genetics
by: Amoah Stephen, et al.
Published: (2012-10-01)

BAGE Hypomethylation Is an Early Event in Colon Transformation and Is Frequent in Histologically Advanced Adenomas
by: Alla Rynditch, et al.
Published: (2009-11-01)

Whole-Genome DNA Methylation Analysis in Hydrogen Peroxide Overproducing Transgenic Tobacco Resistant to Biotic and Abiotic Stresses
by: Ana L. Villagómez-Aranda, et al.
Published: (2021-01-01)

Cross-cell DNA methylation annotation and analysis for pan-cancer study
by: Binhua Tang, et al.
Published: (2016-03-01)

The double-edged sword of (re)expression of genes by hypomethylating agents: from viral mimicry to exploitation as priming agents for targeted immune checkpoint modulation
by: Florian Wolff, et al.
Published: (2017-03-01)

Association of global DNA hypomethylation with clinicopathological variables in colonic tumors of Iraqi patients
by: Ban J Qasim, et al.
Published: (2016-01-01)

The DNA methylome of glioblastoma multiforme
by: Ramon Martinez, et al.
Published: (2010-07-01)

VCAN Hypomethylation and Expression as Predictive Biomarkers of Drug Sensitivity in Upper Urinary Tract Urothelial Carcinoma
by: Hao-Lun Luo, et al.
Published: (2023-04-01)

Pan-cancer analysis of differential DNA methylation patterns
by: Mai Shi, et al.
Published: (2020-10-01)

Consistent DNA Hypomethylations in Prostate Cancer
by: Marcos J. Araúzo-Bravo, et al.
Published: (2022-12-01)

Fusaric acid-induced promoter methylation of DNA methyltransferases triggers DNA hypomethylation in human hepatocellular carcinoma (HepG2) cells
by: Terisha Ghazi, et al.
Published: (2019-08-01)

Ectoine Globally Hypomethylates DNA in Skin Cells and Suppresses Cancer Proliferation
by: Majjid A. Qaria, et al.
Published: (2023-11-01)

<i>SMAD3</i> Hypomethylation as a Biomarker for Early Prediction of Colorectal Cancer
by: Muhamad Ansar, et al.
Published: (2020-10-01)

DNA Hypomethylation Is Associated with the Overexpression of INHBA in Upper Tract Urothelial Carcinoma
by: Chien-Chang Kao, et al.
Published: (2022-02-01)

The Effect of Nanomaterials on DNA Methylation: A Review
by: Ana Valente, et al.
Published: (2023-06-01)

Alteration in TET1 as potential biomarker for immune checkpoint blockade in multiple cancers
by: Hao-Xiang Wu, et al.
Published: (2019-10-01)

DNA hypomethylation of the COX-2 gene promoter is associated with up-regulation of its mRNA expression in eutopic endometrium of endometriosis
by: Wang DanBo, et al.
Published: (2012-05-01)

DNA damage response-related immune activation signature predicts the response to immune checkpoint inhibitors: from gastrointestinal cancer analysis to pan-cancer validation
by: Junya Yan, et al.
Published: (2024-03-01)

Therapeutic Options in Myelodysplastic Syndromes Following Hypomethylating Agent Failure
by: Abigail Belasen, et al.
Published: (2020-07-01)

The early pregnancy placenta foreshadows DNA methylation alterations of solid tumors
by: Akpéli V. Nordor, et al.
Published: (2017-09-01)

Hypomethylation Causes MIR21 Overexpression in Tumors
by: Jun Lu, et al.
Published: (2020-09-01)

Heparanase Gene Hypomethylation as a Potential Biomarker for Precision Screening of Bladder Cancer
by: Bai-sheng Xu, et al.
Published: (2022-07-01)

Identification of Tissue-Specific Gene Clusters Induced by DNA Demethylation in Lung Adenocarcinoma: More Than Germline Genes
by: Anna Diacofotaki, et al.
Published: (2022-02-01)

Systematic analysis of DNA methylation-mediated TF dysregulation on lncRNAs reveals critical roles in tumor immunity
by: Jiaqi Yin, et al.
Published: (2023-12-01)

Global DNA Hypomethylation in Epithelial Ovarian Cancer: Passive Demethylation and Association with Genomic Instability
by: Wa Zhang, et al.
Published: (2020-03-01)

Analysis of DNA methylation patterns in the tumor immune microenvironment of metastatic melanoma
by: Shamik Mitra, et al.
Published: (2020-05-01)

Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC)
by: Yi-fang Lu, et al.
Published: (2018-12-01)

Placental pseudo-malignancy from a DNA methylation perspective: unanswered questions and future directions
by: Boris eNovakovic, et al.
Published: (2013-12-01)

Global Genome Methylation Status in Gastritis Lesion in Comparison with Normal Adjacent Tissue and its Relationship with Clinicopathologic Findings
by: R. Najjar Sadeghi, et al.
Published: (2009-01-01)

DNA Methylation in Lung Cancer: Mechanisms and Associations with Histological Subtypes, Molecular Alterations, and Major Epidemiological Factors
by: Phuc H. Hoang, et al.
Published: (2022-02-01)

The role of TET2-mediated ROBO4 hypomethylation in the development of diabetic retinopathy
by: Liangliang Zhao, et al.
Published: (2023-07-01)

DNA hypomethylator phenotype reprograms glutamatergic network in receptor tyrosine kinase gene-mutated glioblastoma
by: Mio Harachi, et al.
Published: (2024-03-01)

The Emergence of Pan-Cancer CIMP and Its Elusive Interpretation
by: Brendan F. Miller, et al.
Published: (2016-11-01)

The Immuno-Oncology and Genomic Aspects of DNA-Hypomethylating Therapeutics in Acute Myeloid Leukemia
by: Akiko Urabe, et al.
Published: (2023-02-01)

LRRC3B and its promoter hypomethylation status predicts response to anti-PD-1 based immunotherapy
by: Linfeng Luo, et al.
Published: (2023-01-01)